Inspection Record

Be Well Natural Medicine — FDA 483 Findings

US FDAInspected 2022-05-20Published 2022-11-28 4 findingsAseptic processing and sterility assurance

Inspectors Jolanna A Norton · Dustin M JamesThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

Sporicidal agents were not used in your facility's cleanrooms and/or ISO 5 classified aseptic processing area.

2Aseptic processing and sterility assurance

Personnel engaged in aseptic processing were observed wearing non-sterile gloves.

3Aseptic processing and sterility assurance

Materials or supplies were not disinfected prior to entering the aseptic processing areas.

4Aseptic processing and sterility assurance

The ISO 5 classified aseptic processing area was located within a non-classified room (segregated production area).

About this record

Extracted automatically from the document US FDA published on 2022-11-28. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Be Well Natural Medicine company profile — full history US FDA documents, 2022 Go to Findings search